Saltar al contenido
MilliporeSigma

MAB8257B

Anti-Influenza A Antibody, nucleoprotein, clone A1, biotin-conjugated

clone A1, Chemicon®, from mouse

Slide 1 of 1
Iniciar sesión para ver los posibles precios especiales de su organización

Seleccione un Tamaño

100 μG

$432.00

$432.00

Comprobar disponibilidad del carrito
Solicite una orden a granel

Acerca de este artículo

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Documentos clave

Ver Toda la documentación

Saltar a

Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

biological source

mouse

Quality Level

300

conjugate

biotin conjugate

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

A1, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG2a

shipped in

wet ice

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo
MAB8257MAB8257FMAB8671B
Anti-Influenza A Antibody, nucleoprotein, clone A1, biotin-conjugated clone A1, Chemicon®, from mouse

Sigma-Aldrich

MAB8257B

Anti-Influenza A Antibody, nucleoprotein, clone A1, biotin-conjugated

Anticuerpo anti-gripe A, nucleoproteína, clon A1 clone A1, Chemicon®, from mouse

Sigma-Aldrich

MAB8257

Anticuerpo anti-gripe A, nucleoproteína, clon A1

Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated clone A1, Chemicon®, from mouse

Sigma-Aldrich

MAB8257F

Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated

Anti-Influenza B Antibody, Core, clone 22D5-12-13, biotin-conjugated clone 22D5-12-13, Chemicon®, from mouse

Sigma-Aldrich

MAB8671B

Anti-Influenza B Antibody, Core, clone 22D5-12-13, biotin-conjugated

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified antibody

antibody form

purified immunoglobulin

clone

A1, monoclonal

clone

A1, monoclonal

clone

A1, monoclonal

clone

22D5-12-13, monoclonal

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

conjugate

biotin conjugate

conjugate

-

conjugate

FITC conjugate

conjugate

biotin conjugate

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

Immunogen

Epitope: nucleoprotein
Influenza A

Application

Detect Influenza A using this Anti-Influenza A Antibody, nucleoprotein, clone A1, biotin-conjugated validated for use in IF.
Immunofluorescence

Optimal dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A. Has been shown to react with the H5N1 strain. No cross reactivity seen to influenza B or other respiratory viruses.

Physical form

Biotin conjugated purified immunoglobulin. Liquid in 0.01M PBS, pH=7.1, 0.1% Sodium Azide with 15 mg/mL BSA as stabilizer.

Preparation Note

Maintain at 2 to 8°C for up to 12 months from date of receipt. Protect from Light.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Clase de almacenamiento

12 - Non Combustible Liquids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Kai Wu et al.
ACS applied materials & interfaces, 14(8), 9945-9969 (2022-02-16)
The giant magnetoresistance (GMR) effect has seen flourishing development from theory to application in the last three decades since its discovery in 1988. Nowadays, commercial devices based on the GMR effect, such as hard-disk drives, biosensors, magnetic field sensors, microelectromechanical
Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.
Koutsonanos, DG; Vassilieva, EV; Stavropoulou, A; Zarnitsyn, VG; Esser, ES; Taherbhai et al.
Scientific Reports null
David J Holthausen et al.
Immunity, 46(4), 587-595 (2017-04-20)
Although vaccines confer protection against influenza A viruses, antiviral treatment becomes the first line of defense during pandemics because there is insufficient time to produce vaccines. Current antiviral drugs are susceptible to drug resistance, and developing new antivirals is essential.
Mehfuz Zaman et al.
Clinical & translational immunology, 10(9), e1337-e1337 (2021-09-17)
The upper respiratory tract is the major entry site for Streptococcus pyogenes and influenza virus. Vaccine strategies that activate mucosal immunity could significantly reduce morbidity and mortality because of these pathogens. The severity of influenza is significantly greater if a
Felix Broecker et al.
NPJ vaccines, 4, 31-31 (2019-07-26)
Current seasonal influenza virus vaccines only provide limited, short-lived protection, and antigenic drift in the hemagglutinin surface glycoprotein necessitates their annual re-formulation and re-administration. To overcome these limitations, universal vaccine strategies that aim at eliciting broadly protective antibodies to conserved
Ver todos los artículos relacionados

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico